GB1354263A - Therapeutic composition - Google Patents
Therapeutic compositionInfo
- Publication number
- GB1354263A GB1354263A GB2593172A GB2593172A GB1354263A GB 1354263 A GB1354263 A GB 1354263A GB 2593172 A GB2593172 A GB 2593172A GB 2593172 A GB2593172 A GB 2593172A GB 1354263 A GB1354263 A GB 1354263A
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic composition
- june
- therapeutic
- composition
- theranol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract 1
- 102000001974 Hyaluronidases Human genes 0.000 abstract 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 229960002773 hyaluronidase Drugs 0.000 abstract 1
- 229950008325 levothyroxine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- UOWZUVNAGUAEQC-UHFFFAOYSA-N tiratricol Chemical compound IC1=CC(CC(=O)O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 UOWZUVNAGUAEQC-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
1354263 Therapeutic compositions LABORATOIRE THERANOL 2 June 1972 [3 June 1971] 25931/72 Heading A5B A therapeutic composition comprises L-thyroxine (as such or as a salt), 3, 3', 5-triiodothyroacetic acid, and a diffusion factor such as hyaluronidase, dissolved in a pharmaceutically acceptable vehicle which is tooth a solvent for the constituents of the composition and miscible with water, and which contains a wetting agent.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7120183A FR2139748B1 (en) | 1971-06-03 | 1971-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1354263A true GB1354263A (en) | 1974-06-05 |
Family
ID=9078067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2593172A Expired GB1354263A (en) | 1971-06-03 | 1972-06-02 | Therapeutic composition |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS5212779B1 (en) |
| BE (1) | BE784267A (en) |
| CA (1) | CA982477A (en) |
| CH (1) | CH572744A5 (en) |
| DE (1) | DE2226927A1 (en) |
| ES (1) | ES403317A1 (en) |
| FR (1) | FR2139748B1 (en) |
| GB (1) | GB1354263A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040048A3 (en) * | 1995-06-07 | 1997-11-13 | Karobio Ab | Novel uses for thyroid hormones or thyroid hormone-like compounds |
| US6380255B1 (en) | 1995-06-07 | 2002-04-30 | Karo Bio Ab | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| GB2457710A (en) * | 2008-02-25 | 2009-08-26 | Andrew Nicolaou | Thyroxine and its use in weight loss and obesity treatment |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH622703A5 (en) * | 1976-06-10 | 1981-04-30 | Berema Sa | Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite |
| US4525359A (en) * | 1982-12-10 | 1985-06-25 | Greenway Frank L Iii | Treatment for selective weight control |
-
1971
- 1971-06-03 FR FR7120183A patent/FR2139748B1/fr not_active Expired
-
1972
- 1972-05-25 CH CH770672A patent/CH572744A5/xx not_active IP Right Cessation
- 1972-05-30 ES ES403317A patent/ES403317A1/en not_active Expired
- 1972-06-01 BE BE784267A patent/BE784267A/en unknown
- 1972-06-02 GB GB2593172A patent/GB1354263A/en not_active Expired
- 1972-06-02 CA CA143,782A patent/CA982477A/en not_active Expired
- 1972-06-02 DE DE2226927A patent/DE2226927A1/en active Pending
- 1972-06-03 JP JP47055562A patent/JPS5212779B1/ja active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040048A3 (en) * | 1995-06-07 | 1997-11-13 | Karobio Ab | Novel uses for thyroid hormones or thyroid hormone-like compounds |
| US6380255B1 (en) | 1995-06-07 | 2002-04-30 | Karo Bio Ab | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| EP1398024A3 (en) * | 1995-06-07 | 2004-12-15 | Karo Bio Ab | uses for thyroid hormones compounds |
| GB2457710A (en) * | 2008-02-25 | 2009-08-26 | Andrew Nicolaou | Thyroxine and its use in weight loss and obesity treatment |
Also Published As
| Publication number | Publication date |
|---|---|
| BE784267A (en) | 1972-12-01 |
| CA982477A (en) | 1976-01-27 |
| FR2139748A1 (en) | 1973-01-12 |
| DE2226927A1 (en) | 1973-01-18 |
| CH572744A5 (en) | 1976-02-27 |
| FR2139748B1 (en) | 1974-08-30 |
| ES403317A1 (en) | 1976-04-01 |
| JPS5212779B1 (en) | 1977-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES405553A1 (en) | Amino derivatives of pyrazolopyridine carboxylic acids and esters | |
| IE34676B1 (en) | Benzimidazo (2,1-b) quinazolin derivatives as immuno suppressants | |
| CA989864A (en) | Metal derivatives of 3,5-di-t-butyl-hydroxyphenylpropionic acid and compositions containing these derivatives | |
| IE42340L (en) | 11,12-secoprostaglandins | |
| GB1319103A (en) | Alpha,beta-poly aspartic acid-hydroxy-alkylamides | |
| ES419560A1 (en) | N-1-alkoxycarbonyl-ethyl-n-haloacetyl-2,6-dialkylanilines and their microbicidal use | |
| GB1354263A (en) | Therapeutic composition | |
| AU449293B2 (en) | New adenosine-5'carboxylic acid derivatives andthe preparation thereof | |
| GB1403900A (en) | Pharmaceutical composition | |
| GB1362845A (en) | Benzyl alcohol derivatives | |
| IE34609B1 (en) | Antineoplastic therapeutic compositions | |
| GB1463975A (en) | Skin compositions | |
| GB1353834A (en) | Benzenesulphonamides | |
| GB1357564A (en) | Glycoproteins | |
| GB1383259A (en) | 5-hydroxy-1- -5-substituted phenyl furfurylidene- amino - hydantoins | |
| GB1402085A (en) | 15-hydroxy vincamine | |
| GB1254057A (en) | Improvements in or relating to therapeutical composition containing vincamine | |
| GB1465771A (en) | Pharmaceutical composition and use thereofd | |
| GB1287433A (en) | Pharmaceutical compositions | |
| GB1437788A (en) | Therapeutic compositions | |
| FR2081580A1 (en) | Pharmacol-active 2,4,6-trimethoxybenzoates | |
| GB1109964A (en) | Complex of theophylline and soluble saccharin, process for its preparation and therapeutic composition comprising same | |
| GB1233150A (en) | ||
| CA987591A (en) | Bronchodilatory compositions containing quinazoline derivatives for inhalation therapy | |
| GB1330993A (en) | Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |